Hair restoration procedures have seen a steady rise with 60% growth in demand. Learn how the ARTAS IX™ system can help your clinic grow alongside demand.
February 10, 2020
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
The Market Report states that the Global Hair Restoration Services Market size is expected to rise to new levels at a compound annual growth rate of 5.4%, reaching $11.9 billion by 2025. It is indicative that hair restoration has steadily become a popular aesthetic procedure. The treatment is usually sought after by men who suffer from one or more kinds of extreme hair loss or hair thinning. The case for hair loss is primarily attributed to genetic factors and age and is mostly prevalent in males.
With the demand for hair restoration accelerating in growth, ARTAS iX™ is well-poised to help you capitalize on this lucrative market. ARTAS iX™ Robotic Hair Restoration System is the most intelligent solution to hair loss, utilizing the Follicular Unit Extraction (FUE) method it offers a precise and minimally invasive procedure for patients. The system is able to perform repeatable harvesting with simultaneous recipient site-making and implantation, utilizing state-of-the-art robotic and artificial intelligence technology, in one compact platform.
Hair restoration procedures fall into two categories: Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE). Both methods consist of removing hair follicles from the back of the head, better known as the donor area. The primary difference between these two methods is that with FUT, the surgeon removes a strip of skin from the donor area, and then proceeds to extract individual follicular units. With FUE, these very follicular units are individually removed. The latter leaves no linear scar, making it easy to return to daily activities relatively sooner. According to the American Academy of Dermatology (AAD), FUE is growing 39% annually as FUT becomes less popular. The FUE process is quickly gaining momentum as the future of hair restoration as it tackles many pre-existing apprehensions regarding hair restoration such as scars and extensive downtimes.
ARTAS iX™ is a proprietary, patented, and FDA-cleared robotic hair restoration system. The advanced multi-camera stereoscopic vision system with 44-micron resolution and 7-axis robot arm delivers unmatched intelligence, precision, repeatability, and clinical efficiency.
It intelligently analyzes and selects grafts from the donor area with no risk of linear scarring while accurately identifying and creating optimal recipient sites. The existing terminal hair is protected throughout the procedure along with a natural appearance in the donor and implantation areas.
Furthermore, the 3D pre-operative planning feature enables physicians to customize and prescribe the hairline design with the desired angle, direction and density. Given that hair restoration procedures take time, the compact and streamlined ergonomic design makes it easy to use while minimizing the footprint and facilitating clinical efficiency.
The male aesthetics market remains largely untapped with 1.2 billion men, worldwide, suffering from hereditary baldness. This represents an extraordinary opportunity to capture both new patients and new revenue streams for physicians. The ARTAS procedure provides a unique platform to capitalize on this lucrative market size. The American Society of Aesthetic Plastic Surgery (ASAPS) stated that 10% of cosmetic surgeries were performed on males in 2015 with hair restoration being one of the most popular. The ARTAS iX™ Robotic Hair Restoration System uniquely positions your practice as a leader in providing the most advanced technology in hair restoration, thus driving significant revenue opportunities.
For any practice owner looking to launch a hair restoration business, investing in the right equipment is a major decision in the overall process. Learn more about the ARTAS iX™ robotic hair restoration system—contact a Venus Concept expert today using the button below.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More